Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.
about
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Assessment of microtubule-asso ...... erapy for early breast cancer.
@en
Assessment of microtubule-associated protein
@nl
type
label
Assessment of microtubule-asso ...... erapy for early breast cancer.
@en
Assessment of microtubule-associated protein
@nl
prefLabel
Assessment of microtubule-asso ...... erapy for early breast cancer.
@en
Assessment of microtubule-associated protein
@nl
P2093
P2860
P50
P1476
Assessment of microtubule-asso ...... herapy for early breast cancer
@en
P2093
J M S Bartlett
R P A'hern
S Johnston
P2860
P2888
P304
P356
10.1007/S10549-014-2855-4
P407
P577
2014-02-12T00:00:00Z